Basel, Switzerland
SFL, a Veristat company, offers integrated solutions for healthcare products. The company provides consultancy services to pharma, biotech, and medtech companies across all stages of the product life cycle. These services include regulatory affairs and intelligence, quality and supply chain, medical writing, public affairs and market access, pharmacovigilance, and healthcare compliance. Furthermore, SFL can serve as a marketing authorization applicant and MAH in Switzerland and the EU, and handle submissions to authorities such as FDA, PMDA, and Health Canada. As part of Veristat, SFL's clients gain access to a broad range of clinical development services, including global clinical operations, biostatistics, and programming.
Founded in 2009, SFL has established itself as a leader in the industry, offering comprehensive and integrated solutions to its clients. Although the specific industries served by the company are not mentioned, its focus on pharma, biotech, and medtech suggests a strong presence in the life sciences sector.
As the company's last investment details are unavailable, it signifies that the latest investment round and its associated investors are not publicly disclosed. This lack of information may imply multiple scenarios, such as maintaining operations independently without external funding or pursuing non-disclosed funding rounds or investments from private sources.
